Michael Ryskin

Tempus AI Inc (NASDAQ:TEM) announced last week it was granted advanced diagnostic laboratory test status for its next-generation sequencing assay. These analysts provide their initial takeaways from the stock. BofA Securities On Tempus Analyst Michael Ryskin initiated coverage with a Buy rating and...

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last year. Unfortunately for investors, many of the most popular 2021 IPO stocks have...

Singular Genomics Systems Inc (NASDAQ: OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter of 2022, according to BofA Securities. The Singular Genomics Systems Analyst: Michael Ryskin upgraded the rating for Singular...

Schrodinger Inc (NASDAQ: SDGR) reported downbeat third-quarter results, mainly due to lower-than-expected drug discovery revenues, according to BofA Securities. The Schrodinger Analyst: Michael Ryskin downgraded Schrodinger from Buy to Neutral and lowered the price target from $80 to $52...

SmileDirectClub Inc’s (NASDAQ: SDC) stock plummeted after the company reported its third-quarter revenue at $137.68 million, down 18.3% year-on-year, missing the consensus estimate of $181.90 million. BofA on SmileDirectClub: Analyst Michael Ryskin of BofA Securities maintained an...

Zoetis Inc (NYSE: ZTS) seems well-positioned in 2021 with the stock valuation offering an attractive entry point, according to BofA Securities. The Zoetis Analyst: Michael Ryskin upgraded the rating for Zoetis from Neutral to Buy, while maintaining a price target of $180. The Zoetis...

Align Technology, Inc. (NASDAQ: ALGN), a maker of orthodontic products to fix crooked teeth and other issues, has seen a stock gain of more than 130% since March and has "gotten ahead of itself," according to BofA Securities. The company is set to report second-quarter results...

SmileDirectClub Inc’s (NASDAQ: SDC) recovery in aligner shipments and revenue growth in the back half of 2020 and through 2021 is likely to be slower than was earlier anticipated, according to BofA Securities. SmileDirectClub reported quarterly losses of 28 cents per share, which missed the...

SmileDirectClub Inc (NASDAQ: SDC) reported third-quarter results Tuesday that were "good enough" in one Street analyst's view, while another found fault in management's fourth-quarter outlook. The Analysts Bank of America Merrill Lynch analyst Michael Ryskin maintained a Buy...

Last week, Elanco Animal Health Incorporated (NYSE: ELAN) announced plans to acquire Bayer’s (OTC: BAYRY) Animal Health business for $7.6 billion. Although the deal was widely expected, and some details are better than expected, there are questions around the deal that are unlikely to be...

Zoetis Inc’s (NYSE: ZTS) stock has appreciated significantly year-to-date on a continued “safety haven” trade and upside to 2020 results on the basis of the upcoming launch of Simparica Trio, according to Bank of America Merrill Lynch.  The stock appears fairly valued,...

Reviewing the fiscal year fourth-quarter results of Catalent Inc (NYSE: CTLT), the sell side exuded optimism concerning the company. Bank of America Merrill Lynch said the company has had a strong finish to its best year since IPOing, while Wells Fargo Securities said momentum at the company...